The impact of generalized malignant melanoma on quality of life evaluated by the EORTC questionnaire technique

[1]  D. Osoba,et al.  The EORTC Core Quality-of-Life Questionnaire: Interim Results of an International Field Study * , 2021, Effect of Cancer on Quality of Life.

[2]  R. Snaith,et al.  The hospital anxiety and depression scale. , 2013, Acta psychiatrica Scandinavica.

[3]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[4]  D. Guerry,et al.  Disseminated melanoma--is there a new standard therapy? , 1992, The New England journal of medicine.

[5]  C. Boni,et al.  Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen. , 1992, The New England journal of medicine.

[6]  M. Sullivan,et al.  Anxiety and depressive symptoms at different stages of malignant melanoma , 1992 .

[7]  A. Howell,et al.  Psychiatric morbidity in patients with advanced cancer of the breast: prevalence measured by two self-rating questionnaires. , 1991, British Journal of Cancer.

[8]  M. Watson,et al.  The Factor Structure and Factor Stability of the Hospital Anxiety and Depression Scale in Patients with Cancer , 1991, British Journal of Psychiatry.

[9]  Morton Bard,et al.  Quality of life research in oncology. Past achievements and future priorities , 1991, Cancer.

[10]  C. Blomstrand,et al.  Spinal Cord Injuries: Clinical, Functional, and Emotional Status , 1991 .

[11]  H. Strander,et al.  Dacarbazine‐Vindesine‐Cisplatin in Disseminated Malignant Melanoma: A Phase I‐II Trial , 1990, American journal of clinical oncology.

[12]  D. Tulsky,et al.  Measuring quality of life today: methodological aspects. , 1990, Oncology.

[13]  S. Lakhani,et al.  Chemotherapy for malignant melanoma: combinations and high doses produce more responses without survival benefit. , 1990, British Journal of Cancer.

[14]  H. Adami,et al.  Trends in survival from malignant melanoma: remarkable improvement in 23 years. , 1989, Journal of the National Cancer Institute.

[15]  J. Holland,et al.  The relationship of psychological distress, extent of disease, and performance status in patients with lung cancer , 1987, Cancer.

[16]  Longman Aj,et al.  Living with melanoma: content analysis of interviews. , 1986 .

[17]  M. Plumb,et al.  Comparative Studies of Psychological Function in Patients with Advanced Cancer. II. Interviewer‐Rated Current and Past Psychological Symptoms , 1981, Psychosomatic medicine.

[18]  S. Carter,et al.  Integration of chemotherapy into combined modality therapy of solid tumors. IV. Malignant melanoma. , 1974, Cancer treatment reviews.

[19]  S. Carter,et al.  Integration of chemotherapy into combined modality treatment of solid tumors. 1. The overall strategy. , 1974, Cancer treatment reviews.

[20]  N. Nie,et al.  Statistical Package for the Social Sciences , 1970 .

[21]  D. Campbell,et al.  Convergent and discriminant validation by the multitrait-multimethod matrix. , 1959, Psychological bulletin.

[22]  L. Cronbach.  Coefficient alpha and the internal structure of tests , 1951 .

[23]  R. Likert.  “Technique for the Measurement of Attitudes, A” , 2022, The SAGE Encyclopedia of Research Design.

[24]  M. Sullivan,et al.  Quality of life during chemotherapy for small cell lung cancer. II. A longitudinal study of the EORTC Core Quality of Life Questionnaire and comparison with the Sickness Impact Profile. , 1992, Acta oncologica.

[25]  M. Sullivan,et al.  Quality of life during chemotherapy for small cell lung cancer. I. An evaluation with generic health measures. , 1991, Acta oncologica.

[26]  H. Strander,et al.  Dacarbazine versus dacarbazine-vindesine in disseminated malignant melanoma: A randomized phase II study , 1989, Medical oncology and tumor pharmacotherapy.

[27]  S. Kaasa,et al.  Toxicity, physical function and everyday activity reported by patients with inoperable non-small cell lung cancer in a randomized trial (chemotherapy versus radiotherapy). , 1988, Acta oncologica.

[28]  J. de Haes,et al.  The quality of life of cancer patients: a review of the literature. , 1985, Social science & medicine.

[29]  J. Haes,et al.  The quality of life of cancer patients: a review of the literature , 1985 .

[30]  Jensen Om,et al.  Trends in malignant melanoma of the skin. , 1980 .

[31]  J. V. Bradley.  Distribution-Free Statistical Tests , 1968 .

[32]  G. Helmstadter,et al.  Principles of Psychological Measurement , 1964 .